Suppr超能文献

评估阑尾切除术是否为免疫检查点抑制剂相关性肠炎的潜在危险因素。

Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis.

机构信息

Harvard Medical School, Boston, MA 02115, USA.

Department of Vascular Surgery, UMass Memorial Medical Center, Worcester, MA 01605, USA.

出版信息

Immunotherapy. 2023 Aug;15(12):913-920. doi: 10.2217/imt-2022-0245. Epub 2023 Jun 9.

Abstract

The relationship between appendectomy and immune checkpoint inhibitor (ICI) enterocolitis was explored. Patients who began ICIs between July 2010 and September 2020 (n = 10,907) were included. The exposure group included patients with evidence of appendectomy prior to ICIs in operative notes (n = 380). The control group included patients with evidence of normal appendix in radiologic reports (n = 3602). ICI enterocolitis was defined as histopathologic evidence of colitis or enteritis attributed to ICIs. The association between appendectomy and ICI enterocolitis was characterized by multivariate logistic regression. 248 patients (6.2%) developed ICI enterocolitis. The odds of ICI enterocolitis were similar among those with prior appendectomy and those without appendectomy (adjusted odds ratio: 0.82; 95% CI: 0.49-1.36; p = 0.449). No association was found between prior appendectomy and ICI enterocolitis.

摘要

研究了阑尾切除术与免疫检查点抑制剂(ICI)结肠炎之间的关系。纳入了 2010 年 7 月至 2020 年 9 月期间开始接受 ICI 治疗的患者(n=10907)。暴露组包括手术记录中有 ICI 前阑尾切除术证据的患者(n=380)。对照组包括影像学报告中有正常阑尾证据的患者(n=3602)。ICI 结肠炎的定义为组织病理学证据表明结肠炎或肠炎归因于 ICI。阑尾切除术与 ICI 结肠炎之间的关联通过多变量逻辑回归进行描述。248 名患者(6.2%)发生 ICI 结肠炎。有或没有阑尾切除术的患者发生 ICI 结肠炎的几率相似(调整后的优势比:0.82;95%CI:0.49-1.36;p=0.449)。先前的阑尾切除术与 ICI 结肠炎之间没有关联。

相似文献

1
Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis.
Immunotherapy. 2023 Aug;15(12):913-920. doi: 10.2217/imt-2022-0245. Epub 2023 Jun 9.
5
Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review.
Clin Gastroenterol Hepatol. 2020 May;18(6):1393-1403.e1. doi: 10.1016/j.cgh.2020.01.033. Epub 2020 Jan 31.
7
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis.
JCO Oncol Pract. 2020 Sep;16(9):e933-e942. doi: 10.1200/JOP.19.00672. Epub 2020 May 13.
8
Gastrointestinal mucosal toxicities from immune checkpoint inhibitors: Current understanding and future directions.
Immunol Rev. 2023 Sep;318(1):11-21. doi: 10.1111/imr.13239. Epub 2023 Jul 16.
9
Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Kurume Med J. 2023 Jul 3;68(2):43-52. doi: 10.2739/kurumemedj.MS682006. Epub 2023 Apr 26.
10
Gut Microbiome and Immune Checkpoint Inhibitor-Induced Enterocolitis.
Dig Dis Sci. 2020 Mar;65(3):797-799. doi: 10.1007/s10620-020-06103-x.

本文引用的文献

1
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.
Nat Med. 2022 Feb;28(2):353-362. doi: 10.1038/s41591-021-01623-z. Epub 2022 Jan 13.
2
Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.
Front Immunol. 2021 Dec 21;12:800879. doi: 10.3389/fimmu.2021.800879. eCollection 2021.
3
Appendectomy Is Associated With Alteration of Human Gut Bacterial and Fungal Communities.
Front Microbiol. 2021 Sep 16;12:724980. doi: 10.3389/fmicb.2021.724980. eCollection 2021.
5
Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Cancer Immunol Immunother. 2021 Nov;70(11):3069-3080. doi: 10.1007/s00262-021-02996-3. Epub 2021 Jun 30.
7
Interferon-Gamma-Producing CD8 Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Gastroenterology. 2021 Oct;161(4):1229-1244.e9. doi: 10.1053/j.gastro.2021.06.025. Epub 2021 Jun 17.
8
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.
Annu Rev Pathol. 2021 Jan 24;16:223-249. doi: 10.1146/annurev-pathol-042020-042741. Epub 2020 Nov 16.
9
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.
Gastroenterology. 2021 Mar;160(4):1384-1393. doi: 10.1053/j.gastro.2020.08.063. Epub 2020 Oct 17.
10
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Cell. 2020 Aug 6;182(3):655-671.e22. doi: 10.1016/j.cell.2020.06.001. Epub 2020 Jun 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验